Table 1.
Characteristics of Patients With Intestinal Ischemia During COVID-19 Infection
| Patient no. | Age, y | Sex | Ongoing ACT/APT | Entry symptoms | CT/endoscopy findings | D-dimer | Outcome |
|---|---|---|---|---|---|---|---|
| 1 | 85 | Male | ASA + DOAC | Low GI bleeding | CT and endoscopy: ischemic colitis | Not done | Discharged |
| 2 | 71 | Female | ASA | Loss of appetite, vomiting, low GI bleeding | Endoscopy: ischemic colitis | 10 N | Discharged |
| 3 | 69 | Male | No | Diarrhea, fever, and dyspnea | CT: ischemic colitis (right colon) | 8 N | Death |
| 4 | 79 | Female | LMWH | Abdominal pain | CT: SB ischemia with SB occlusion; splenic infarcts | 8 N | Discharged |
| 5 | 63 | Male | No | Lower limb pain | CT: right and transverse colon ischemia; splenic infarcts | >70 N | Death |
| 6 | 62 | Male | No | Abdominal pain and vomiting | CT: SB ischemia with SMV and IVC thrombosis | >70 N | Death |
| 7 | 83 | Female | LMWH | Dyspnea and abdominal pain | CT: SB and colon ischemia | 3 N | Death |
ACT, anticoagulant therapy; APT, antiplatelet therapy; ASA, acetylsalicylic acid; CT, computed tomography, DOAC, direct oral anticoagulant; GI, gastrointestinal; IVC, inferior vena cava; LMWH, low-molecular-weight heparin; SB, small bowel; SMV, superior mesenteric vein.